Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24269599)

1.

Clinical presentation and outcome of adult-type granulosa cell tumors: a retrospective study of 30 patients in a single institute.

Huang BS, Sun HD, Hsu YM, Chang WH, Horng HC, Yen MS, Chao KC, Edmond Hsieh SL, Wang PH.

J Chin Med Assoc. 2014 Jan;77(1):21-5. doi: 10.1016/j.jcma.2013.09.007. Epub 2013 Oct 23.

PMID:
24269599
2.

Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?

Ottolina J, Ferrandina G, Gadducci A, Scollo P, Lorusso D, Giorda G, Breda E, Savarese A, Candiani M, Zullo F, Mangili G.

Gynecol Oncol. 2015 Feb;136(2):230-4. doi: 10.1016/j.ygyno.2014.12.016. Epub 2014 Dec 17.

PMID:
25527364
3.

Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor: a 56-year single-center experience.

Bryk S, Färkkilä A, Bützow R, Leminen A, Heikinheimo M, Anttonen M, Riska A, Unkila-Kallio L.

Int J Gynecol Cancer. 2015 Jan;25(1):33-41. doi: 10.1097/IGC.0000000000000304.

PMID:
25347095
4.

Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.

Wang WC, Lai YC.

J Ovarian Res. 2014 Sep 6;7:88. doi: 10.1186/s13048-014-0088-0.

5.

The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U.

Int J Mol Sci. 2014 Aug 27;15(9):15161-72. doi: 10.3390/ijms150915161.

6.

Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report.

Momeni M, Kalir T, Farag S, Chuang L, Fishman D, Burstein DE.

Cell Oncol (Dordr). 2014 Jun;37(3):229-34. doi: 10.1007/s13402-014-0174-8. Epub 2014 Jul 15.

PMID:
25023763
7.

A Long-term follow-up study of 91 cases with ovarian granulosa cell tumors.

Shim SH, Lee SJ, Kim DY, Kim J, Kim SN, Kang SB, Kim JH, Kim YM, Kim YT, Nam JH.

Anticancer Res. 2014 Feb;34(2):1001-10.

PMID:
24511046
8.

Ovarian granulosa cell tumor and increased risk of breast cancer.

Hammer A, Lauszus FF, Petersen AC.

Acta Obstet Gynecol Scand. 2013 Dec;92(12):1422-5. doi: 10.1111/aogs.12252. Epub 2013 Oct 28.

PMID:
24283356
9.

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.

Pitta Dda R, Sarian LO, Barreta A, Campos EA, Andrade LL, Fachini AM, Campbell LM, Derchain S.

BMC Cancer. 2013 Sep 18;13:423. doi: 10.1186/1471-2407-13-423.

10.

Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.

Rosario R, Wilson M, Cheng WT, Payne K, Cohen PA, Fong P, Shelling AN.

Gynecol Oncol. 2013 Nov;131(2):325-9. doi: 10.1016/j.ygyno.2013.08.031. Epub 2013 Sep 2.

PMID:
24007948
11.

Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors.

Suri A, Carter EB, Horowitz N, Denslow S, Gehrig PA.

Gynecol Oncol. 2013 Nov;131(2):321-4. doi: 10.1016/j.ygyno.2013.08.013. Epub 2013 Aug 27.

PMID:
23994106
12.

Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels.

Chao A, Lee LY, Hsueh C, Lin CY, Tsai CL, Chao AS, Lin CT, Chou HH, Chang TC, Wang TH.

Taiwan J Obstet Gynecol. 2013 Jun;52(2):185-91. doi: 10.1016/j.tjog.2013.04.006.

PMID:
23915849
13.

Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumors.

Stine JE, Suri A, Gehrig PA, Chiu M, Erickson BK, Huh WK, Soper JT, Van Le L, Conner MG, Kim KH.

Gynecol Oncol. 2013 Oct;131(1):59-62. doi: 10.1016/j.ygyno.2013.06.030. Epub 2013 Jun 29.

PMID:
23820112
14.

Ovarian granulosa cell tumors: a retrospective study of 27 cases and a review of the literature.

Sekkate S, Kairouani M, Serji B, Tazi A, Mrabti H, Boutayeb S, Errihani H.

World J Surg Oncol. 2013 Jun 18;11:142. doi: 10.1186/1477-7819-11-142.

15.

Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary.

Mangili G, Ottolina J, Gadducci A, Giorda G, Breda E, Savarese A, Candiani M, Frigerio L, Scarfone G, Pignata S, Rossi R, Marinaccio M, Lorusso D.

Br J Cancer. 2013 Jul 9;109(1):29-34. doi: 10.1038/bjc.2013.241. Epub 2013 Jun 11.

16.

Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.

Mangili G, Sigismondi C, Frigerio L, Candiani M, Savarese A, Giorda G, Lauria R, Tamberi S, Greggi S, Lorusso D.

Gynecol Oncol. 2013 Jul;130(1):38-42. doi: 10.1016/j.ygyno.2013.04.047. Epub 2013 Apr 25.

PMID:
23623833
17.

Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.

Numanoglu C, Kuru O, Sakinci M, Akbayır O, Ulker V.

Aust N Z J Obstet Gynaecol. 2013 Jun;53(3):287-92. doi: 10.1111/ajo.12090. Epub 2013 Apr 23.

PMID:
23611791
18.

14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.

Chen L, Yang B.

Int J Gynecol Pathol. 2013 Mar;32(2):156-62. doi: 10.1097/PGP.0b013e31825a0353.

PMID:
23370648
19.

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.

Sandri MT, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, Peiretti M, Radice D, Passerini R, Sideri M.

Gynecol Oncol. 2013 Feb;128(2):233-8. doi: 10.1016/j.ygyno.2012.11.026. Epub 2012 Nov 28.

PMID:
23200911
20.

HE4 and ROMA index in Czech postmenopausal women.

Novotny Z, Presl J, Kucera R, Topolcan O, Vrzalova J, Fuchsova R, Betincova L, Rokyta Z.

Anticancer Res. 2012 Sep;32(9):4137-40.

PMID:
22993374
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk